News Image

NYSE:DOCS—A High-Growth Stock Gearing Up for Its Next Upward Move.

By Mill Chart

Last update: Mar 12, 2024

In this article, we'll take a closer look at DOXIMITY INC-CLASS A (NYSE:DOCS) as a potential candidate for growth investing. While it's important for investors to conduct their own research, DOXIMITY INC-CLASS A has piqued our interest by appearing on our strong growth and breakout radar. Let's explore further.

What does the Growth looks like for NYSE:DOCS

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NYSE:DOCS has received a 8 out of 10:

  • The Earnings Per Share has grown by an impressive 21.62% over the past year.
  • DOCS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 106.72% yearly.
  • Looking at the last year, DOCS shows a quite strong growth in Revenue. The Revenue has grown by 16.57% in the last year.
  • Measured over the past years, DOCS shows a very strong growth in Revenue. The Revenue has been growing by 53.27% on average per year.
  • The Earnings Per Share is expected to grow by 13.19% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 11.62% on average over the next years. This is quite good.

Health Assessment of NYSE:DOCS

ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NYSE:DOCS has earned a 9 out of 10:

  • An Altman-Z score of 24.76 indicates that DOCS is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 24.76, DOCS belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • There is no outstanding debt for DOCS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
  • A Current Ratio of 8.03 indicates that DOCS has no problem at all paying its short term obligations.
  • DOCS has a Current ratio of 8.03. This is amongst the best in the industry. DOCS outperforms 92.31% of its industry peers.
  • A Quick Ratio of 8.03 indicates that DOCS has no problem at all paying its short term obligations.
  • DOCS has a Quick ratio of 8.03. This is amongst the best in the industry. DOCS outperforms 92.31% of its industry peers.

Profitability Examination for NYSE:DOCS

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NYSE:DOCS has achieved a 9:

  • Looking at the Return On Assets, with a value of 13.76%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • DOCS has a Return On Equity of 15.92%. This is amongst the best in the industry. DOCS outperforms 97.44% of its industry peers.
  • DOCS's Return On Invested Capital of 15.40% is amongst the best of the industry. DOCS outperforms 100.00% of its industry peers.
  • DOCS had an Average Return On Invested Capital over the past 3 years of 17.25%. This is significantly above the industry average of 4.96%.
  • DOCS has a better Profit Margin (29.39%) than 100.00% of its industry peers.
  • DOCS's Profit Margin has improved in the last couple of years.
  • DOCS's Operating Margin of 34.75% is amongst the best of the industry. DOCS outperforms 100.00% of its industry peers.
  • DOCS's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 88.94%, DOCS belongs to the top of the industry, outperforming 97.44% of the companies in the same industry.

Looking at the Setup

Alongside the Technical Rating, ChartMill assigns a Setup Rating to evaluate the consolidation level of a stock. This rating, ranging from 0 to 10, is updated daily and considers various short-term technical indicators. The current setup rating for NYSE:DOCS is 8:

DOCS has a bad technical rating, but it does show a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 28.71. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 27.49, a Stop Loss order could be placed below this zone.

Every day, new Strong Growth stocks can be found on ChartMill in our Strong Growth screener.

Check the latest full fundamental report of DOCS for a complete fundamental analysis.

Check the latest full technical report of DOCS for a complete technical analysis.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

DOXIMITY INC-CLASS A

NYSE:DOCS (4/25/2024, 7:04:00 PM)

After market: 23.59 0 (0%)

23.59

-0.32 (-1.34%)

DOCS News

News Image2 hours ago - Bragar Eagel & SquireBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, and Doximity Innovations and Encourages Investors to Contact the Firm
News Image7 hours ago - DoximityDoximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024
News Image7 hours ago - Law Offices of Howard G. SmithINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) Investors
News Imagea day ago - The Rosen Law Firm PAROSEN, LEADING INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
News Imagea day ago - Schall LawINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm
News Image2 days ago - DiCello Levitt LLPDiCello Levitt LLP Announces Investor Lawsuit Filed Against Doximity, Inc. (NYSE: DOCS) and Lead Plaintiff Deadline
News Image2 days ago - Bronstein, Gewirtz & Grossman, LLCDOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

/PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has...

News Image2 days ago - Market News VideoDoximity Becomes Oversold (DOCS)
News Image2 days ago - The Rosen Law Firm, P.A.DOCS INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
News Image3 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCS

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). Such...

News Image3 days ago - Robbins LLPDoximity, Inc. (DOCS) Investor Notice: Robbins LLP Reminds Stockholders of the Doximity, Inc. Shareholder Class Action
News Image3 days ago - Faruqi & Faruqi LLPDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity
DOCS Links
Follow us for more